Contribution of Estrogen Receptors to the Strategy of Breast Cancer Treatment (original) (raw)

1981

Abstract

Polychemotherapy and hormonal therapy are currently the major therapeutic modalities in advanced breast cancer. The former is the most effective (≥ 50 percent response rate) but the second is less toxic, with a response rate of about 30%. The recent development of estrogen receptor determination in breast cancer tissue samples has improved the clinician’s ability to use these modalities either separately or together in an optimum manner.

Guy Leclercq hasn't uploaded this paper.

Let Guy know you want this paper to be uploaded.

Ask for this paper to be uploaded.